These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6865856)

  • 1. Some theoretical derivations relating to the tissue dosimetry of brachytherapy nuclides, with particular reference to iodine-125.
    Dale RG
    Med Phys; 1983; 10(2):176-83. PubMed ID: 6865856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Monte Carlo derivation of parameters for use in the tissue dosimetry of medium and low energy nuclides.
    Dale RG
    Br J Radiol; 1982 Oct; 55(658):748-57. PubMed ID: 7127026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monte Carlo radiation dose simulations and dosimetric comparison of the model 6711 and 9011 125I brachytherapy sources.
    Rivard MJ
    Med Phys; 2009 Feb; 36(2):486-91. PubMed ID: 19291987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An approach to using conventional brachytherapy software for clinical treatment planning of complex, Monte Carlo-based brachytherapy dose distributions.
    Rivard MJ; Melhus CS; Granero D; Perez-Calatayud J; Ballester F
    Med Phys; 2009 Jun; 36(6):1968-75. PubMed ID: 19610285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric characteristic of a new 125I brachytherapy source.
    Sadeghi M; Khanmohammadi Z
    Radiat Prot Dosimetry; 2011 Nov; 147(3):451-6. PubMed ID: 21233096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
    Medich DC; Munro JJ
    Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
    Bohm TD; DeLuca PM; DeWerd LA
    Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comment on "Dosimetry of the I-Plant Model 3500 iodine-125 brachytherapy source".
    Cohen GN; Worman MF
    Med Phys; 2003 Nov; 30(11):3040-3; author reply 3044. PubMed ID: 14655951
    [No Abstract]   [Full Text] [Related]  

  • 9. Phantom size in brachytherapy source dosimetric studies.
    Pérez-Calatayud J; Granero D; Ballester F
    Med Phys; 2004 Jul; 31(7):2075-81. PubMed ID: 15305460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGS4 dosimetry calculations for cylindrically symmetric brachytherapy sources.
    Wang R; Sloboda RS
    Med Phys; 1996 Aug; 23(8):1459-65. PubMed ID: 8873045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed.
    Lymperopoulou G; Papagiannis P; Sakelliou L; Karaiskos P; Sandilos P; Przykutta A; Baltas D
    Med Phys; 2005 Nov; 32(11):3313-7. PubMed ID: 16370418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Monte Carlo evaluation of the dosimetric characteristics of the EchoSeed Model 6733 (125)I brachytherapy source.
    Sowards KT; Meigooni AS
    Brachytherapy; 2002; 1(4):227-32. PubMed ID: 15062171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental and Monte Carlo determination of the TG-43 dosimetric parameters for the model 9011 THINSeed brachytherapy source.
    Kennedy RM; Davis SD; Micka JA; DeWerd LA
    Med Phys; 2010 Apr; 37(4):1681-8. PubMed ID: 20443489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the IsoAid ADVANTAGE (125)I brachytherapy source dosimetric parameters using Monte Carlo simulation.
    Sadeghi M; Hamed Hosseini S
    Appl Radiat Isot; 2010 Jan; 68(1):211-3. PubMed ID: 19762248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of solid phantoms with water for dosimetry of 125I brachytherapy sources.
    Meigooni AS; Meli JA; Nath R
    Med Phys; 1988; 15(5):695-701. PubMed ID: 3185404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
    Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
    Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of K-edge 125I brachytherapy enhancement with silver compounds.
    Young LA; Phillips MH; Nelson JA
    Phys Med Biol; 1999 Aug; 44(8):1921-35. PubMed ID: 10473205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive dosimetric comparison between (131)Cs and (125)I brachytherapy sources for COMS eye plaque implant.
    Zhang H; Martin D; Chiu-Tsao ST; Meigooni A; Thomadsen BR
    Brachytherapy; 2010; 9(4):362-72. PubMed ID: 20116342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAPM TG-43U1 formalism adaptation and monte carlo dosimetry simulations of multiple-radionuclide brachytherapy sources.
    Nuttens VE; Lucas S
    Med Phys; 2006 Apr; 33(4):1101-7. PubMed ID: 16696487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rigid phantom dosimetry of brachytherapy sources, with special reference to 125-I].
    Arcovito G; Piermattei A; Bacci C; Pittella G; Castagnola M
    Radiol Med; 1985 Jun; 71(6):426-32. PubMed ID: 4070702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.